Table 3 Metabolic characteristics of child survivors of leukemia and lymphoma according to treatment received at first assessment

 n: number (%)

17

15 (47)

12

5 (29)

 Sex (M)

12

12

9

4

 Current age (Y)

12.1 (8.1, 17.0)

12 (7.1, 17.0)

12.6 (7.1, 16.1)

12.1 (8.0, 17.1)

 Age at cancer diagnosis (Y)

6.0 (2.0, 13.0)

4.0 (2.0, 12.1)

6.5 (0.08, 12.1)

7 (1.0, 11.1)

 Time since completion of therapy (Y)

4.0 (2.0, 5.1)

4.0 (2.1, 5.1)

3.1 (3.0, 5.0)

4.0 (2.0, 5.0)

Weight (kg)

Height (cm)

 Diagnosis : ALL/Lymphoma

11/6

9/6

4/8

1/4

 1

9

13*

5

3

 ≥ 2

8

2

7

2

 WC (pc)

25 (10, 75)

90 (50, 100)*

50 (10, 90)

90 (75, 100)

 SBP (pc)

47 (3, 92)

53 (18, 93)

17 (2, 65)

47 (20, 99)

 DBP (pc)

76 (15, 94)

82 (57, 99)

75 (19, 96)

89 (39, 99)

 Triglicerydes (mg/dL)

76 (34, 149)

114 (50, 231)

72 (35, 164)

188 (148, 210)

 HDL-C (mg/dL)

42 (25, 84)

39.5 (26, 78)

42 (18, 64)

43 (18, 48)

 Glucose (mg/dL)

90 (75.5, 115.7)

91 (76, 105.7)

86 (74, 112.5)

93 (82, 99)

 Insulin (μU/mL)

16.3 (9.1, 38.7)

24.9 (14.2, 35.3)*

20.5 (4.3, 50)

36.3 (19, 55)

 HOMA-IR

3.6 (1.7, 9.5)

5.5 (2.8, 8.2)*

4.3 (0.79, 13.9)

8.3 (4.7, 12.7)

 Adiponectin (μg/mL)

23 (1.3, 44.3)

22 (6.8, 70)

19.1 (11.7, 41.2)

16 (1.3, 27.6)

 Adiponectin per Kg fat (μg/mL/kg)

1.5 (0.39, 6.7)

1.2 (0.28, 4.9)

1.8 (0.51, 5.1)

0.75 (0.7, 1.8)

 Leptin ((μg/mL)

4.4 (2, 13.4)

18.2 (9.8, 30.9)*

7.4 (1.2, 19.0)

17.5 (13.5, 18.5)

 Leptin per Kg fat (μg/mL/kg)

0.49 (0.11, 3.0)

1.0 (0.34, 3.7)*

0.46 (0.16, 3.9)

0.72 (0.53, 1.31)

 Leptin to Adiponectin ratio

0.27 (0.08, 2.7)

0.98 (0.20, 3.0)*

0.33 (0.06, 0.76)

0.85 (0.67, 11.0)

 Body Fat (%)

23.4, (9.9, 36.2)

38.3 (32.0, 46.7)*

27.4 (8.3, 38.1)

37.1 (28.5, 40.2)

 VCAM (ng/mL)

1058 (561, 1727)

818 (425, 1730)

856 (586, 1207)

989 (490, 1697)

 ICAM (ng/mL)

459 (254, 661)

418 (294, 1079)

500 (265, 952)

398 (324, 598)

 Yes/No

0/17

4/11

1/11

2/3